These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26267431)

  • 21. Severe phototoxicity associated with long-term voriconazole treatment.
    Vöhringer S; Schrum J; Ott H; Höger PH
    J Dtsch Dermatol Ges; 2011 Apr; 9(4):274-6. PubMed ID: 21050383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dronaderone-induced phototoxicity.
    Ladizinski B; Elpern DJ
    J Drugs Dermatol; 2013 Aug; 12(8):946-7. PubMed ID: 23986170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The "Heart Sign": An Early Indicator of Dose-Dependent Doxycycline-Induced Phototoxicity.
    Nguyen TA; Krakowski AC
    Pediatr Dermatol; 2016; 33(2):e69-71. PubMed ID: 26764127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe phototoxicity associated with concomitant use of methotrexate and voriconazole, an overlooked drug-drug interaction.
    Bogaert DJ; Verlinden L; Vandecruys E; Laureys G; Verhaeghe E; Bauters T
    Pediatr Blood Cancer; 2020 Jun; 67(6):e28246. PubMed ID: 32207558
    [No Abstract]   [Full Text] [Related]  

  • 25. Salazosulfapyridine-induced hypersensitivity syndrome triggered by methotrexate.
    Teraki Y; Izaki S
    Clin Exp Dermatol; 2009 Oct; 34(7):e287-8. PubMed ID: 19438549
    [No Abstract]   [Full Text] [Related]  

  • 26. Which light source should be used for the investigation of clinical phototoxicity: monochromator or solar simulator?
    Moseley H; Ferguson J
    Photodermatol Photoimmunol Photomed; 2010 Feb; 26(1):3-6. PubMed ID: 20070831
    [No Abstract]   [Full Text] [Related]  

  • 27. Worsening pneumonitis due to a pharmacokinetic drug-drug interaction between everolimus and voriconazole in a renal transplant patient.
    Lecefel C; Eloy P; Chauvin B; Wyplosz B; Amilien V; Massias L; Taburet AM; Francois H; Furlan V
    J Clin Pharm Ther; 2015 Feb; 40(1):119-20. PubMed ID: 25417855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phototoxic dermatoses in pediatric BMT patients receiving voriconazole.
    Goyal RK; Gehris RP; Howrie D; Cogley KM; Windreich RM; Venkataramanan R
    Pediatr Blood Cancer; 2014 Jul; 61(7):1325-8. PubMed ID: 24619922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Voriconazole-induced periostitis post transplant: an illustrative review of thoracic computed tomography imaging manifestations.
    Rheinboldt M; Delproposto Z; Agarwal R
    Transpl Infect Dis; 2015 Dec; 17(6):859-63. PubMed ID: 26346289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the Effectiveness of Additional Risk Minimization Measures for Voriconazole in the EU: Findings and Lessons Learned from a Healthcare Professional Survey.
    Lem J; Younus M; Aram JA; Moosavi S; Freivogel K; Lewis A; Sobel RE
    Pharmaceut Med; 2019 Apr; 33(2):121-133. PubMed ID: 31933256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultraviolet recall reaction after total body irradiation, etoposide, and methotrexate therapy.
    Goldfeder KL; Levin JM; Katz KA; Clarke LE; Loren AW; James WD
    J Am Acad Dermatol; 2007 Mar; 56(3):494-9. PubMed ID: 17187896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localized inflammatory reactions at sites of subcutaneous methotrexate injections during treatment with ultraviolet B.
    Muthiah S; Charlton F; Farr PM
    Br J Dermatol; 2018 Jul; 179(1):192-194. PubMed ID: 29341063
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of the phototoxic potential of plants used in oriental medicine.
    Bark KM; Heo EP; Han KD; Kim MB; Lee ST; Gil EM; Kim TH
    J Ethnopharmacol; 2010 Jan; 127(1):11-8. PubMed ID: 19818392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A drug-related phototoxic reaction and its possible relationship to a radiation-induced skin reaction.
    Dawson GA; Brown SI; Tellefsen L
    Oncologist; 2009 Mar; 14(3):303-6. PubMed ID: 19325133
    [No Abstract]   [Full Text] [Related]  

  • 35. [Photoxicity reaction due to methotrexate].
    Fernández RJ; Jordá PA; Fernández-Navarro JM; Sales AA; Ramiro AN; Miralles AV
    An Pediatr (Barc); 2012 Mar; 76(3):179-80. PubMed ID: 22104021
    [No Abstract]   [Full Text] [Related]  

  • 36. Local reaction after subcutaneous injection of methotrexate: uncommon side effect.
    Priego-Recio CM; Camacho-Martínez FM
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):523-4. PubMed ID: 25546179
    [No Abstract]   [Full Text] [Related]  

  • 37. Voriconazole-induced periostitis in a patient with overlap syndromes.
    Hirota K; Yasoda A; Fujii T; Inagaki N
    BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24599432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [4pp Mucocutaneous manifestations of methotrexate toxicity].
    Ferrari B; Kogan N; Veira RC; Luna PC; Larralde M; Cuesta MG; Díaz P; Rossi MV; Aloise I
    Medicina (B Aires); 2018; 78(1):50-53. PubMed ID: 29360079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Voriconazole-induced skeletal fluorosis in an allogenic hematopoietic stem cell transplant recipient.
    Thekkudan SF; Kumar P; Nityanand S
    Ann Hematol; 2016 Mar; 95(4):669-70. PubMed ID: 26820975
    [No Abstract]   [Full Text] [Related]  

  • 40. Successful desensitization of voriconazole in an immunosuppressed pediatric patient.
    Jean T; Kwong K
    J Allergy Clin Immunol Pract; 2015; 3(4):637-8. PubMed ID: 25800818
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.